H Wuttke

724 total citations
25 papers, 535 citations indexed

About

H Wuttke is a scholar working on Pharmacology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, H Wuttke has authored 25 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in H Wuttke's work include Pharmacogenetics and Drug Metabolism (6 papers), Mycobacterium research and diagnosis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). H Wuttke is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Mycobacterium research and diagnosis (3 papers) and Inflammatory mediators and NSAID effects (3 papers). H Wuttke collaborates with scholars based in Germany, United States and France. H Wuttke's co-authors include Thomas Rau, Thomas Eschenhagen, Klaus von Bergmann, Ulrike Werner, R. Heide, Michael Böhm, Dierk Werner, Joachim Weil, Martin F. Fromm and Marko Kreft and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

H Wuttke

24 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Wuttke Germany 8 245 230 78 74 70 25 535
Richard P. Koshakji United States 14 145 0.6× 145 0.6× 89 1.1× 45 0.6× 79 1.1× 22 594
JH Silas United Kingdom 10 218 0.9× 96 0.4× 51 0.7× 55 0.7× 60 0.9× 17 412
R. E. Vestal United States 8 146 0.6× 151 0.7× 70 0.9× 46 0.6× 129 1.8× 12 607
R. Zacest Australia 12 123 0.5× 224 1.0× 161 2.1× 80 1.1× 114 1.6× 24 749
D S Hewick United Kingdom 11 262 1.1× 117 0.5× 140 1.8× 44 0.6× 79 1.1× 32 641
H.F. Woods United Kingdom 8 328 1.3× 98 0.4× 126 1.6× 77 1.0× 102 1.5× 9 708
M J Serlin United Kingdom 11 234 1.0× 213 0.9× 70 0.9× 34 0.5× 171 2.4× 17 712
K. Reiff United States 9 98 0.4× 187 0.8× 59 0.8× 66 0.9× 66 0.9× 16 515
P. Collste Sweden 16 124 0.5× 141 0.6× 46 0.6× 69 0.9× 95 1.4× 24 529
PR Jackson United Kingdom 11 151 0.6× 115 0.5× 51 0.7× 117 1.6× 47 0.7× 21 459

Countries citing papers authored by H Wuttke

Since Specialization
Citations

This map shows the geographic impact of H Wuttke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Wuttke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Wuttke more than expected).

Fields of papers citing papers by H Wuttke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Wuttke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Wuttke. The network helps show where H Wuttke may publish in the future.

Co-authorship network of co-authors of H Wuttke

This figure shows the co-authorship network connecting the top 25 collaborators of H Wuttke. A scholar is included among the top collaborators of H Wuttke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Wuttke. H Wuttke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rau, Thomas, H Wuttke, Ulrike Werner, et al.. (2008). Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study. Clinical Pharmacology & Therapeutics. 85(3). 269–272. 92 indexed citations
2.
Werner, Ulrike, Constanze Lamprecht, Dierk Werner, et al.. (2006). Valdecoxib does not interfere with the CYP2D6 substrate metoprolol. International Journal of Clinical Pharmacology and Therapeutics. 44(9). 397–400. 2 indexed citations
3.
Wuttke, H, Thomas Rau, & Thomas Eschenhagen. (2004). Genpolymorphismen in Arzneimittel-abbauenden Enzymen. DMW - Deutsche Medizinische Wochenschrift. 129(15). 831–835. 7 indexed citations
4.
Hinz, Burkhard, Bertold Renner, H Wuttke, et al.. (2004). Bioavailability of diclofenac potassium at low doses. British Journal of Clinical Pharmacology. 59(1). 80–84. 58 indexed citations
5.
Werner, Dierk, H Wuttke, Martin F. Fromm, et al.. (2004). Effect of amiodarone on the plasma levels of metoprolol. The American Journal of Cardiology. 94(10). 1319–1321. 27 indexed citations
6.
Kindermann, Michael, Christoph Maack, K. Schmidt, et al.. (2004). Carvedilol but Not Metoprolol Reduces β-Adrenergic Responsiveness After Complete Elimination From Plasma In Vivo. Circulation. 109(25). 3182–3190. 44 indexed citations
7.
Rau, Thomas, R. Heide, Klaus von Bergmann, et al.. (2002). Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics. 12(6). 465–472. 105 indexed citations
8.
Wuttke, H, Thomas Rau, R. Heide, et al.. (2002). Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol‐associated adverse effects. Clinical Pharmacology & Therapeutics. 72(4). 429–437. 129 indexed citations
9.
Maack, Christoph, Thomas Elter, Georg Nickenig, et al.. (2001). Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure. Journal of the American College of Cardiology. 38(4). 939–946. 38 indexed citations
10.
Wuttke, H, et al.. (1979). Die endokrine Orbitopathie bei diffuser Hyperthyreose unter thyreostatischer Therapie. Journal of Molecular Medicine. 57(2). 69–74. 1 indexed citations
11.
Wuttke, H, et al.. (1976). Die Emboliegefahr bei der Ultraschall-Thrombolyse. Langenbeck s Archives of Surgery. 340(3). 199–205. 5 indexed citations
12.
Wuttke, H, et al.. (1976). [Clinical significance of serum magnesium concentration in thyrotoxicosis (author's transl)].. PubMed. 71(6). 235–8. 2 indexed citations
13.
Wuttke, H, et al.. (1974). Prevention of hypo magnesemia in experimental hyper thyroidism. Research in Experimental Medicine. 164(2). 157–168. 1 indexed citations
14.
Wuttke, H. (1974). Lymphogranulomatose mit Toxoplasmose-Enzephalitis. DMW - Deutsche Medizinische Wochenschrift. 99(34). 1689–1691. 2 indexed citations
15.
Wuttke, H, et al.. (1971). [Morphokinetic effect of thyrotrope hormone on the C-cells of the thyroid gland].. PubMed. 155(1). 20–31. 1 indexed citations
16.
Wuttke, H, et al.. (1971). Morphokinetischer Einfluß des thyreotropen Hormons auf die C-Zellen der Schilddrüse. Research in Experimental Medicine. 155(1). 20–31. 4 indexed citations
17.
Wuttke, H, et al.. (1969). Das Verhalten des Serum-Magnesiums bei experimenteller Hyperthyreose und bei gleichzeitiger Anwendung eines Aldosteron-Antagonisten. Journal of Molecular Medicine. 47(23). 1282–1283. 1 indexed citations
18.
19.
Wuttke, H, et al.. (1967). [Further studies on the in vitro demonstration of cell-bound antibodies in tuberculosis with reference to the clinical aspects and humoral antibodies against tuberculin].. PubMed. 342(1). 1–7. 2 indexed citations
20.
Wuttke, H, et al.. (1966). �ber den Nachweis zellgebundener Antik�rper in vitro. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 341(2). 133–141. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard P. Koshakji Breakdown of academic impact, for papers by JH Silas Breakdown of academic impact, for papers by R. E. Vestal Breakdown of academic impact, for papers by R. Zacest Breakdown of academic impact, for papers by D S Hewick Breakdown of academic impact, for papers by H.F. Woods Breakdown of academic impact, for papers by M J Serlin Breakdown of academic impact, for papers by K. Reiff Breakdown of academic impact, for papers by P. Collste Breakdown of academic impact, for papers by PR Jackson
Rankless by CCL
2026